MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$1,162,614
(6.38%↑ Y/Y)
Technology Fees
$3,636,720
(7.39%↑ Y/Y)
Device Sales
$351,099
(50.99%↑ Y/Y)
Net loss
attributable to common...
-$1,148,067
(12.93%↑ Y/Y)
Translation adjustment
-$14,547
(-118.97%↓ Y/Y)
Revenue
$3,987,819
(10.19%↑ Y/Y)
Net loss before
dividends
-$717,067
(41.66%↑ Y/Y)
Preferred stock dividends
$431,000
(382.15%↑ Y/Y)
Gross profit
$3,251,476
(17.64%↑ Y/Y)
Cost of revenue
$736,343
(-13.89%↓ Y/Y)
Net loss before
income taxes
-$717,067
(41.66%↑ Y/Y)
(loss) profit from
operations
$440,915
(360.92%↑ Y/Y)
Gain/(loss) upon
convertible promissory...
$11,409
(165.73%↑ Y/Y)
Total operating
expenses
$2,810,561
(-4.17%↓ Y/Y)
Interest expense
$810,339
(-4.61%↓ Y/Y)
Accretion and
amortization expenses
-$185,470
(36.29%↑ Y/Y)
Change in fair value of
derivative liabilities...
-$134,335
(-515.40%↓ Y/Y)
Other
income/(expense)
-$39,247
(-159.91%↓ Y/Y)
Selling, general and
administrative expenses
$2,186,994
(-8.18%↓ Y/Y)
Research and development
expenses
$623,567
(13.13%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)